Selvita to open new lab in Poland

By Staff Reporter

- Last updated on GMT

Selvita to open new lab in Poland
Discovery services firm Selvita plans a new laboratory in Poland citing a desired to develop the facility as its “second heart.”

The laboratory will be at the Wielkopolska Centre of Advanced Technologies in Poznan where Selvita has leased a 5,500 sqft unit. The facility, which is due to open this summer, will increase the contract services’ firm’s capacity by 20%.

Krakov-headquartered firm said it initially plans to employ 50 chemists and biologist at the laboratory. However, it plans to increase headcount over time and establish the facility as the "second heart of Selvita​.”

Board member Dr. Miroslawa Zydron said: “Wielkopolska region has a fantastic scientific potential. We are fully aware that for many talented graduates from local universities, the decision to relocate to Krakow can be very difficult, and for this reason we decided to come to them​."

She added that: "Recently we have been recruiting locally in Poznan​” explaining that “candidates are being invited to join Selvita for a few months in Krakow, so they can have the opportunity to get to know our company and its organization, before they start working in Poznan.​"

Selvita said that in addition to offering drug discovery services to customers, the new laboratory will also “actively participating in internal R&D projects.”

The planned expansion is in keeping with the strategy Selvita has followed since completing its initial public offering (IPO) at the end of 2014.

Last year the firm set up two offices in Boston and San Francisco in the US citing proximity to customers as the driver.

Related news

Related products

show more

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules | 09-Oct-2023 | White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...

Related suppliers

Follow us

Products

View more

Webinars